Variable expression of the mutation in familial defective apolipoprotein B-100.
Author(s) -
John J. Gallagher,
N. B. Myant
Publication year - 1993
Publication title -
arteriosclerosis and thrombosis a journal of vascular biology
Language(s) - English
Resource type - Journals
eISSN - 2330-9199
pISSN - 1049-8834
DOI - 10.1161/01.atv.13.7.973
Subject(s) - apolipoprotein b , heterozygote advantage , allele , locus (genetics) , genetics , biology , endocrinology , lipoprotein , ldl receptor , familial hypercholesterolemia , medicine , cholesterol , gene
Although most subjects with familial defective apolipoprotein B-100 (FDB) have raised plasma low-density lipoprotein (LDL) levels, a few have LDL levels within the normal range. We have previously identified two normocholesterolemic FDB heterozygotes in an affected family. Results obtained from a study of this family are compatible with a major genetic contribution to the normocholesterolemia in the two heterozygotes. However, our findings are not compatible with inheritance of a variant normal allele at the apolipoprotein B locus in this family that neutralizes the effect of an FDB allele on the plasma LDL level. Polymorphic variations at the apolipoprotein E and LDL receptor loci did not explain the presence of normal LDL levels in the two heterozygous FDB subjects.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom